225 related articles for article (PubMed ID: 30108111)
1. Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis.
Nayak MK; Dhanesha N; Doddapattar P; Rodriguez O; Sonkar VK; Dayal S; Chauhan AK
Blood Adv; 2018 Aug; 2(15):2029-2038. PubMed ID: 30108111
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis.
Flora GD; Nayak MK; Ghatge M; Kumskova M; Patel RB; Chauhan AK
Blood Adv; 2023 Jun; 7(11):2347-2359. PubMed ID: 36971790
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial calcium uniporter b deletion inhibits platelet function and reduces susceptibility to arterial thrombosis.
Ghatge M; Nayak MK; Flora GD; Kumskova M; Jain A; Patel RB; Lin Z; Usachev YM; Chauhan AK
J Thromb Haemost; 2023 Aug; 21(8):2163-2174. PubMed ID: 37061131
[TBL] [Abstract][Full Text] [Related]
4. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
Zhang W; Hu X; Zhou W; Tam KY
J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
7. The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis.
Nayak MK; Ghatge M; Flora GD; Dhanesha N; Jain M; Markan KR; Potthoff MJ; Lentz SR; Chauhan AK
Blood; 2021 Mar; 137(12):1658-1668. PubMed ID: 33027814
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol-3,4,5-trisphosphate stimulates Ca(2+) elevation and Akt phosphorylation to constitute a major mechanism of thromboxane A2 formation in human platelets.
Kassouf N; Ambily A; Watson S; Hassock S; Authi HS; Srivastava S; Watson SP; Authi KS
Cell Signal; 2015 Jul; 27(7):1488-98. PubMed ID: 25797048
[TBL] [Abstract][Full Text] [Related]
9. Receptor-interacting protein kinase 3 promotes platelet activation and thrombosis.
Zhang Y; Zhang J; Yan R; Tian J; Zhang Y; Zhang J; Chen M; Cui Q; Zhao L; Hu R; Jiang M; Li Z; Ruan C; He S; Dai K
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):2964-2969. PubMed ID: 28242694
[TBL] [Abstract][Full Text] [Related]
10. Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis.
Delaney MK; Kim K; Estevez B; Xu Z; Stojanovic-Terpo A; Shen B; Ushio-Fukai M; Cho J; Du X
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):846-54. PubMed ID: 26988594
[TBL] [Abstract][Full Text] [Related]
11. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
[TBL] [Abstract][Full Text] [Related]
12. Fruitflow inhibits platelet function by suppressing Akt/GSK3β, Syk/PLCγ2 and p38 MAPK phosphorylation in collagen-stimulated platelets.
Chen H; Zhang S; Wang H; Bao L; Wu W; Qi R
BMC Complement Med Ther; 2022 Mar; 22(1):75. PubMed ID: 35300669
[TBL] [Abstract][Full Text] [Related]
13. Platycodin D inhibits platelet function and thrombus formation through inducing internalization of platelet glycoprotein receptors.
Luo Q; Wei G; Wu X; Tang K; Xu M; Wu Y; Liu Y; Li X; Sun Z; Ju W; Qi K; Chen C; Yan Z; Cheng H; Zhu F; Li Z; Zeng L; Xu K; Qiao J
J Transl Med; 2018 Nov; 16(1):311. PubMed ID: 30442147
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate.
Ferriero R; Iannuzzi C; Manco G; Brunetti-Pierri N
J Inherit Metab Dis; 2015 Sep; 38(5):895-904. PubMed ID: 25601413
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells.
Ho N; Coomber BL
Exp Cell Res; 2015 Feb; 331(1):73-81. PubMed ID: 25536473
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
Stacpoole PW
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.
Michelakis ED; Gurtu V; Webster L; Barnes G; Watson G; Howard L; Cupitt J; Paterson I; Thompson RB; Chow K; O'Regan DP; Zhao L; Wharton J; Kiely DG; Kinnaird A; Boukouris AE; White C; Nagendran J; Freed DH; Wort SJ; Gibbs JSR; Wilkins MR
Sci Transl Med; 2017 Oct; 9(413):. PubMed ID: 29070699
[TBL] [Abstract][Full Text] [Related]
18. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.
Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F
Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201
[TBL] [Abstract][Full Text] [Related]
19. Eugenol Suppresses Platelet Activation and Mitigates Pulmonary Thromboembolism in Humans and Murine Models.
Huang WC; Shu LH; Kuo YJ; Lai KS; Hsia CW; Yen TL; Hsia CH; Jayakumar T; Yang CH; Sheu JR
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396774
[TBL] [Abstract][Full Text] [Related]
20. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR
mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
